Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
04/12/2001 | WO2001025445A1 Fibrinolytically active polypeptide |
04/12/2001 | WO2001025442A1 Dna polymerase lambda and uses thereof |
04/12/2001 | WO2001025437A2 Growth factor polypeptides and nucleic acids encoding same |
04/12/2001 | WO2001025436A2 Endozepine-like polypeptides and polynucleotides encoding same |
04/12/2001 | WO2001025434A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
04/12/2001 | WO2001025433A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
04/12/2001 | WO2001025430A2 Novel human membrane proteins |
04/12/2001 | WO2001025426A1 Gene encoding protein capable of regenerating luciferin, novel recombinant dna and process for producing protein capable of regenerating luciferin |
04/12/2001 | WO2001025423A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
04/12/2001 | WO2001025422A2 Antisense compositions and cancer-treatment methods |
04/12/2001 | WO2001025419A1 ALTERING GENE EXPRESSION WITH ssDNA PRODUCED IN VIVO |
04/12/2001 | WO2001025405A1 C-myc antisense-treated hematopoietic stem cell composition and method |
04/12/2001 | WO2001025404A1 Methods for inhibiting osteoclast formation or methods for inhibiting bone resorption |
04/12/2001 | WO2001025403A2 Bio-artificial substrate for the production of animal and, in particular, human tissues and organs |
04/12/2001 | WO2001025402A1 Isolation of precursor cells and their use for tissue repair |
04/12/2001 | WO2001025401A2 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
04/12/2001 | WO2001025398A2 Process for inducing functional tolerance to gene transfer products |
04/12/2001 | WO2001025321A1 3d matrix for producing cell transplants |
04/12/2001 | WO2001025282A1 Il13 mutants |
04/12/2001 | WO2001025281A1 Ouabain-specific monoclonal antibodies |
04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
04/12/2001 | WO2001025258A1 Human inwardly rectifying potassium channel subunit |
04/12/2001 | WO2001025253A2 Temperature-sensitive regulation of viral vector production |
04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
04/12/2001 | WO2001024818A1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific t cell responses |
04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
04/12/2001 | WO2001024764A2 Cell targeting compositions and methods of using the same |
04/12/2001 | WO2001024616A1 Method of constructing male sterile plant |
04/12/2001 | WO2000071157A3 New vaccine formulations - 1 |
04/12/2001 | WO2000064458A3 Method for inducing a donor tolerance in the human body |
04/12/2001 | WO2000061755A3 Secreted human proteins |
04/12/2001 | WO2000060058A3 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
04/12/2001 | WO2000049166A3 Production of helper dependent adenovirus vectors based on use of endonucleases |
04/12/2001 | WO2000039289A3 Endo-beta-1,4-xylanase inhibitor aus weizenmehl und seine wirkung auf verschiedene xylanasen |
04/12/2001 | WO2000031241A3 Polypeptides having choline oxidase activity and nucleic acids encoding same |
04/12/2001 | WO2000006199A8 Kvlqt1 - a long qt syndrome gene |
04/12/2001 | WO1999067283A3 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
04/12/2001 | WO1997020056A3 Enhancer-increased gene expression in plants |
04/12/2001 | WO1997004099A3 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
04/12/2001 | WO1996037601B1 Cell differentiation agents |
04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
04/12/2001 | CA2388229A1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific t cell responses |
04/12/2001 | CA2386854A1 Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins |
04/12/2001 | CA2386546A1 Adeno-associated viruses and uses thereof |
04/12/2001 | CA2386519A1 Ouabain-specific monoclonal antibodies |
04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
04/12/2001 | CA2386377A1 Cell targeting compositions and methods of using the same |
04/12/2001 | CA2386252A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
04/12/2001 | CA2386248A1 Il13 mutants |
04/12/2001 | CA2386246A1 Altering gene expression with ssdna produced in vivo |
04/12/2001 | CA2386236A1 Human inwardly rectifying potassium channel subunit |
04/12/2001 | CA2386199A1 Endozepine-like polypeptides and polynucleotides encoding same |
04/12/2001 | CA2386192A1 C-myc antisense-treated hematopoietic stem cell composition and method |
04/12/2001 | CA2386189A1 Novel human membrane proteins |
04/12/2001 | CA2386185A1 Fibrinolytically active polypeptide |
04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
04/12/2001 | CA2385220A1 Antisense compositions and cancer-treatment methods |
04/12/2001 | CA2385127A1 Novel hepatoma-derived growth factor-like proteins, polynulceotides encoding them and methods of use |
04/12/2001 | CA2385032A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
04/12/2001 | CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
04/12/2001 | CA2354043A1 Methods for inhibiting osteoclast formation or methods for inhibiting bone resorption |
04/12/2001 | CA2353083A1 Method of constructing male sterile plant |
04/11/2001 | EP1090999A2 Plant with modified flowers |
04/11/2001 | EP1090991A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
04/11/2001 | EP1090990A1 Human g-protein-coupled receptor |
04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
04/11/2001 | EP1090985A1 Feline-derived T-cells |
04/11/2001 | EP1090984A2 Process for the production, the transport and the elimination of biochemical products with biological active cells |
04/11/2001 | EP1090928A1 Polymers loaded with bioactive agents |
04/11/2001 | EP1090927A1 Polypeptide (scFv) for the detection and removal of CA19-9 antigen positive cells |
04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
04/11/2001 | EP1090925A1 Human G-protein coupled receptor |
04/11/2001 | EP1090300A1 Assay to indicate the presence of non-fertilisable ova |
04/11/2001 | EP1090294A1 Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof |
04/11/2001 | EP1090135A2 Methods to screen herbicidal compounds utilizing air synthetase from arabidopsis thaliana |
04/11/2001 | EP1090131A1 HUMAN GLYCOPROTEASE-LIKE PROTEINS AND DNAs ENCODING THESE PROTEINS |
04/11/2001 | EP1090130A1 Protein c derivatives |
04/11/2001 | EP1090128A1 Modified vitamin-k-dependent polypeptides |
04/11/2001 | EP1090125A2 Dna encoding methymycin and pikromycin |
04/11/2001 | EP1090124A2 MATERIALS AND METHODS FOR THE ALTERATION OF ENZYME AND ACETYL CoA LEVELS IN PLANTS |
04/11/2001 | EP1090123A2 Polyketides and their synthesis |
04/11/2001 | EP1090121A1 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms |
04/11/2001 | EP1090118A2 Human signal peptide-containing proteins |
04/11/2001 | EP1090112A1 Human arf-related proteins |
04/11/2001 | EP1090110A2 Human vault rna |
04/11/2001 | EP1090107A1 Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cells and hybridomas for their production |
04/11/2001 | EP1090106A2 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function |
04/11/2001 | EP1090105A1 Ependymal neural stem cells and method for their isolation |
04/11/2001 | EP1090104A1 Methods of expanding and selecting disease associated t-cells |
04/11/2001 | EP1090038A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
04/11/2001 | EP0900282A4 Ob receptor isoforms and nucleic acids encoding them |
04/11/2001 | EP0876492A4 Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells |
04/11/2001 | EP0710285B1 Analogues of an anti-thrombin polypeptide and process for their preparation |
04/11/2001 | CN1291234A Isolated and purified mucleic acids comprising a gene specifically expressed in hop glands |
04/11/2001 | CN1291233A Human complement (3-degrading proteinase from i (streptococcus pheumoniae) |
04/11/2001 | CN1291232A Method for producing biotin |
04/11/2001 | CN1291231A Human telomerase catalytic subunit |
04/11/2001 | CN1291229A Recombinant active human zona pellucida protein 3 (h2P3) |
04/11/2001 | CN1291228A Enzyme catalyzed therapeutic agents |